Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. [electronic resource]
Producer: 20080829Description: 160-4 p. digitalISSN:- 0002-9149
- Angina Pectoris -- drug therapy
- Angina, Unstable -- drug therapy
- Angioplasty, Balloon, Coronary -- adverse effects
- Anticoagulants -- adverse effects
- Female
- Hemorrhage -- chemically induced
- Heparin -- adverse effects
- Hirudins -- adverse effects
- Humans
- Male
- Middle Aged
- Peptide Fragments -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Postoperative Complications
- Recombinant Proteins -- adverse effects
- Risk Assessment
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.